Two dimensional vs three-dimentional imaging in whole boby oncologic PET/CT: A discovery-STE phantom and patient study

Quarterly Journal of Nuclear Medicine and Molecular Imaging

Volumn 51, Issue 3, 2007, Pages 214-223

  Bettinardi, Valentino ^a,c   Mancosu, P ^a   Danna, M ^a   Giovacchini, G ^a   Landoni, C ^a   Picchio, M ^a   Gilardi, M C ^a   Savi, A ^a   Castiglioni, I ^a   Lecchi, M ^b   Fazio, F ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Computed tomography; Neoplasms; Tomography, emission computed

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; BIOMEDICAL TECHNOLOGY ASSESSMENT; CANCER; CANCER PATIENT; CANCER SIZE; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTED TOMOGRAPHY SCANNER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; INTERMETHOD COMPARISON; OBSERVER VARIATION; PHANTOM; PHYSICIAN; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SENSITIVITY AND SPECIFICITY; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING; WHOLE BODY CT; WHOLE BODY PET; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; EVALUATION; IMAGE ENHANCEMENT; IMAGE SUBTRACTION; INSTRUMENTATION; METHODOLOGY; NEOPLASM; POSITRON EMISSION TOMOGRAPHY; REPRODUCIBILITY; WHOLE BODY IMAGING;

HUMANS; IMAGE ENHANCEMENT; IMAGING, THREE-DIMENSIONAL; NEOPLASMS; PHANTOMS, IMAGING; POSITRON-EMISSION TOMOGRAPHY; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED; WHOLE BODY IMAGING;

EID: 34547547456     PISSN: 18244785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Badawi RD, Marsden PK, Cronin BF, Sutcliffe JL, Maisey MN. Optimization of injected dose based on noise equivalent count rates in 3D PET. Phys Med Biol 1996;41:1755-76.
2. Lartizien C, Comtat C, Kinahan PE, Ferreira N, Bendriem B, Trebossen R. Optimization of injected dose based on noise equivalent count rates for 2- and 3-dimensional whole body PET. J Nucl Med 2002;43:1268-78.
3. 18F-FDG required for whole body PET using an LSO PET camera. Eur J Nucl Med Mol Imaging 2003;30:1615-9.
4. Halpern BS, Dahlbom M, Quon A, Schiepers C, Waldherr C, Silverman DH. Impact of patient weight and emission scan duration on PET/CT image quality and lesion detectability. J Nucl Med 2004;45:797-801.
5. Dhawan V, Kazumata K, Robeson W, Belakhlef A, Margouleff C, Chaly T et al. Quantitative brain PET. Comparison of 2D and 3D acquisitions on the GE advance scanner. Clin Positron Imaging 1998; 1:135-44.
6. Raylman RR, Kinson PV, Wahl RL. Capabilities of two- and three-dimensional FDG-PET for detecting small lesions and lymph nodes in the upper torso: a dynamic phantom study. Eur J Nucl Med 1999;26:39-45.
7. Kadrmas DJ, Christian PE, Wollenweber SD, Kolmyer SG, Stearn CW. Comparative evaluation of 2D and 3D lesion detectability on a full-ring BGO PET scanner. J Nucl Med 2002;43 Suppl:204P.
8. Visvikis D, Griffiths D, Costa DC, Ell PJ. Comparison of clinical 2D and 3D PET imaging using BGO based dedicated system. Eur J Nucl Med Mol Imaging 2003;30:S331.
9. Lartizien C, Kinahan PE, Comtat C. A lesion detection observer study comparing 2-dimensional versus 3-dimensional whole body PET imaging protocols. J Nucl Med 2004;45:714-23.
10. Visvikis D, Griffiths D, Costa DC, Bomanij J, Ell PJ. Clinical evaluation of 2D versus 3D whole-body PET image quality using a dedicated BGO PET scanner. Eur J Nucl Med Mol Imaging 2005;32:1050-6.
11. 18F-FDG PET oncology studies performed on an LSO-based scanner. J Nucl Med 2006; 47:23-31.
12. El Fakhri G, Holdsworth C, Badawi RD, Santos PA, Moore SC, Van den Abbeele AD et al Impact of acquisition geometry and patient habitus on lesion detectability in whole-body FDG-PET: a channelized hotelling observer study. Conference Proceedings of the 2002 IEEE Nuclear Science Symposium and Medical Imaging Conference, Norfolk, VA, USA, 2002.
13. National Electrical Manufacturers Association. NEMA Standards Publication NU-2-2001: performance measurements of positron emission tomographs. Rosslyn, VA: National Electrical Manufacturers Association; 2001.
14. Iatrou M, Ross SG, Manjeshwar RM, Stearns CW. A fully 3D iterative reconstruction algorithm incorporating data corrections. Conference Record of the 2004 IEEE Nuclear Science Symposium and Medical Imaging Conference, Rome, Italy, October 2004.
15. Burgess AE. The Rose model, revisited. J Opt Soc Am 1999;16:633-46.
16. Bono A, Tomotis S, Batoli C, Tragni G, Radaelli G, Maurichi A et al The ABC system of melanoma detection. A spectrophotometric analysis of the asymmetry, border, color and dimension. Cancer 1999; 85:72-7.
17. Knesaurek K, Machac J, Krynyckyi BR, Almeida OD. Comparison of 2-dimensional and 3-dimensional 82Rb myocardial perfusion PET imaging. J Nucl Med 2003;44:1350-6.
18. Roelants V, Bol A, Bernard X, Coppens A, Melin J, Gerber B, Vanoverschelde JL. Direct comparison between 2-dimensional and 3-dimensional PET acquisition modes for myocardial blood flow absolute quantification with O-15 water and N-13 ammonia. J Nucl Cardiol 2006;13:220-4
19. Adam LE, Karp JS, Brix G. Investigation of scatter radiation in 3D whole-body positron emission tomography using Monte Carlo simulations. Phys Med Biol 1999;44:2879-95.
20. Accorsi R, Adam LE, Werner ME, Karp JS. Optimization of a fully 3D scatter simulation algorithm for 3D PET. Phys Med Biol 2004;49:2577-98.